New-onset Hidradenitis Suppurativa Secondary to Combination Therapy with Programmed Cell Death Ligand-1 Inhibitor Atezolizumab and Vascular Endothelial Growth Factor Inhibitor Bevacizumab
BRITISH JOURNAL OF DERMATOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined